NEW ORLEANS, Aug. 8, 2025 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 16, 2025 to file lead plaintiff applications in a securities class action lawsuit against Neogen Corporation (NasdaqGS: NEOG), if they purchased...
Related Questions
What historical price reaction has NEOG exhibited in response to comparable legal disclosures?
Are there any insider or institutional holdings that might be liquidating in response to the lawsuit news?
Could the lawsuit trigger a short‑selling rally or increase in put‑option activity on NEOG options?
How does this lawsuit compare to similar securities class actions faced by peers in the biotech sector?
Will the outcome of the lawsuit affect Neogen's ability to fund ongoing R&D projects or acquisitions?
How likely is it that the class action lawsuit will result in a material settlement or judgment against Neogen Corporation?
What are the potential tax or accounting implications for shareholders who may receive a settlement or judgment in the future?
What is the potential impact of the lead plaintiff deadline on NEOG's short-term stock volatility?
How might the lawsuit influence analyst coverage and earnings forecasts for Neogen Corporation?
What is the estimated total exposure of shareholders to the alleged losses exceeding $100,000?